Also known as

Mod GRF 1-29 · CJC-1295 without DAC · Tetrasubstituted GHRH(1-29)

Overview

CJC-1295 without DAC (often called Mod GRF 1-29) is a GHRH analog designed for shorter-acting GH-pulse research compared with DAC-extended versions. It is used to study physiologic-like GH secretion patterns in laboratory models.

Frequently paired with GHRPs such as ipamorelin in multi-ligand designs. Left Turn Adventures supplies this compound for laboratory and research use only.

Proven benefits

Note: Preclinical / literature endpoints for labs — not established human treatment benefits. Not a protocol.

• GHRH-receptor and GH-pulse endpoints

• - IGF-1 pathway markers in short-acting designs

• - Pulsatility research versus DAC-extended CJC

• - Recovery and composition co-markers where studied

• - GHRH-analog pharmacology in GH-axis catalogs

Results timeline

Note: Illustrative research-observation windows — not a clinical schedule. No dosing.

• Week 1–2: GH-axis pulse and IGF-related markers beginning to register in short observation windows.

• - Week 3–4: Clearer GH/IGF pathway readouts and recovery-adjacent markers in research models.

• - Month 2–3: Body-composition and soft-tissue endpoints more apparent in extended preclinical designs.

• - Month 3–6: Sustained GH-axis and composition-related observations where protocols run longer.

Footer RUO

The catalog, not a clinic

For laboratory and research use only. Not for human or animal consumption. Products are sold solely to qualified researchers and licensed laboratories. No dosing or reconstitution on this page.